424TiPPhase 1b multi-indication study of the antibody drug conjugate anetumab ravtansine in patients with mesothelin-expressing advanced or recurrent malignanciesA. A. Adjei,A. Walter,Lisa Cupit,J. Siegel, A. Holynskyj,Barrett H. Childs,C. ElbiANNALS OF ONCOLOGY（2018）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
